FECS-Ad

N/A

Report date: 2023/09/01 20:00:50

Base Information

Drug NameFECS-Ad

Drug Alias NameFECS-Ad (S. Biomedics)FECS-AdFECSAd

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionCell replacements

TargetsUpdating

Therapy Area/IndicationsIschemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesS.Biomedics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesS.Biomedics Co Ltd

Inactive CompaniesN/A

Active IndicationsIschemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A